Arizona Health Center COVID-19 Survey Summary Report

Latest data from October 8, 2021

Number of Health Center respondents = 19 (83% of all Health Centers)

Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.

Patients Tested

Metrics Value
Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 8,149
Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) 75.00%
Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 1,178
Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) 71.16%

Patients by Race and Ethnicity

Race/Ethnicity Patients Tested, Virus Detection (PCR, antigen)2 Patients Tested Positive, Virus Detection (PCR, antigen)2
White, Non-Hispanic/Latino Patients 20.46% 23.26%
White, Hispanic/Latino Patients 38.93% 37.18%
Black/African American, Non-Hispanic/Latino Patients 3.63% 2.97%
Black/African American, Hispanic/Latino Patients 0.39% 0.25%
Asian Patients3 0.83% 0.59%
American Indian/Alaska Native Patients3 4.09% 4.50%
Native Hawaiian/Other Pacific Islander Patients3 0.18% 0.17%
Patients with More than one race3 4.91% 4.50%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 8.41% 7.22%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.27% 1.53%
Unreported/Refused to Report Race and Ethnicity 15.90% 17.83%

Patients Vaccinated

Metrics Value
COVID-19 Immunization Series Initiated 2,414
Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization 82.48%
COVID-19 Immunization Series Completed 3,012
Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization 83.47%
COVID-19 Immunization Series Additional 427
Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine 67.35%

Vaccinations by Race and Ethnicity

Race/Ethnicity Patient COVID-19 Immunization Series Initiated2 Patient COVID-19 Immunization Series Completed2 Patient COVID-19 Immunization Series Additional2
White, Non-Hispanic/Latino Patients 12.92% 12.02% 26.00%
White, Hispanic/Latino Patients 37.32% 40.54% 39.58%
Black/African American, Non-Hispanic/Latino Patients 4.97% 3.85% 4.68%
Black/African American, Hispanic/Latino Patients 0.37% 0.03% 0.00%
Asian Patients3 1.20% 0.73% 1.64%
American Indian/Alaska Native Patients3 1.28% 0.80% 0.94%
Native Hawaiian/Other Pacific Islander Patients3 0.41% 0.37% 0.00%
Patients with More than one race3 4.81% 4.28% 0.94%
Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 10.48% 10.09% 5.85%
Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) 2.82% 2.86% 2.58%
Unreported/Refused to Report Race and Ethnicity 23.41% 24.44% 17.80%

Testing Logistics

Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)

Metrics Value
Less Than 1 Hour 15.79%
1 to 24 Hours 31.58%
More Than 24 Hours 52.63%
N/A 0.00%

Vaccine Logistics

Challenges in Deploying the COVID Vaccine

Metrics Value
Financial reimbursement for costs associated with vaccine administration 0.00%
Staffing to administer the vaccine 31.58%
Vaccine confidence 47.37%
Vaccine storage capacity 5.26%
Vaccine supply 0.00%
Other 0.00%
None 26.32%

Operations and Staff

Metrics Value
COVID-19 Vaccine Doses Received Only From Health Center COVID-19 Vaccine Program 42.11%
Average Percent of Health Center Visits Conducted Virtually 23.95%

Mobile Vans, Pop-Up Clinics, and School-Based Sites

Metrics Value
Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics 47.37%
Number of Mobile Van Sites 8
Number of Pop-up Clinics 33
Number of School-Based Vaccination Sites 5

Monoclonal Antibody Therapy

Methods in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Direct provision of monoclonal antibody therapies 5.26%
Refer patients to another organization that provides monoclonal antibody therapies 36.84%
None 57.89%

Challenges in Providing Access to Monoclonal Antibody Therapy

Metrics Value
Access to therapeutics 5.26%
Patient awareness/education 10.53%
Staffing capacity 10.53%
Therapy administration/onsite logistics 26.32%
Other 5.26%
None 42.11%

1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.

2 Percentages may not add to 100% due to rounding to the hundredths.

3 Includes Hispanic/Latino and Non-Hispanic/Latino.

Date Last Reviewed:  October 2021